Mitochondrial function as a therapeutic target in heart failure

DA Brown, JB Perry, ME Allen, HN Sabbah… - Nature Reviews …, 2017 - nature.com
Heart failure is a pressing worldwide public-health problem with millions of patients having
worsening heart failure. Despite all the available therapies, the condition carries a very poor …

[HTML][HTML] Mitochondrial pharmacology

RAJ Smith, RC Hartley, HM Cocheme… - Trends in pharmacological …, 2012 - cell.com
Mitochondria are being recognized as key factors in many unexpected areas of biomedical
science. In addition to their well-known roles in oxidative phosphorylation and metabolism, it …

Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications

AS Manolis, AA Manolis, TA Manolis… - Medicinal Research …, 2021 - Wiley Online Library
Mitochondria provide energy to the cell during aerobic respiration by supplying~ 95% of the
adenosine triphosphate (ATP) molecules via oxidative phosphorylation. These organelles …

Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload

Q Hong, K Qi, Z Feng, Z Huang, S Cui, L Wang, B Fu… - Cell calcium, 2012 - Elsevier
BACKGROUND: Uric acid (UA) has proven to be a causal agent in endothelial dysfunction
in which ROS production plays an important role. Calcium overload in mitochondria can …

The Role of Ca2+ Signaling in Aging and Neurodegeneration: Insights from Caenorhabditis elegans Models

J Alvarez, P Alvarez-Illera, P García-Casas, RI Fonteriz… - Cells, 2020 - mdpi.com
Ca2+ is a ubiquitous second messenger that plays an essential role in physiological
processes such as muscle contraction, neuronal secretion, and cell proliferation or …

Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia/reperfusion injury

DA Brown, HN Sabbah, SR Shaikh - Pharmacology & therapeutics, 2013 - Elsevier
A major manifestation of coronary artery disease is cardiac ischemia/reperfusion injury, with
the extent of injury directly relating to short-and long-term prognosis. Emerging evidence …

Gramine Derivatives Targeting Ca2+ Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases

R Lajarin-Cuesta, C Nanclares… - Journal of medicinal …, 2016 - ACS Publications
We describe the synthesis of gramine derivatives and their pharmacological evaluation as
multipotent drugs for the treatment of Alzheimer's disease. An innovative multitarget …

Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease

JC Fernandez-Morales, JA Arranz-Tagarro… - ACS chemical …, 2012 - ACS Publications
For the last two decades, most efforts on new drug development to treat Alzheimer's disease
have been focused to inhibit the synthesis of amyloid beta (Aβ), to prevent Aβ deposition, or …

Benzothiazepine CGP37157 and its 2′-isopropyl analogue modulate Ca2+ entry through CALHM1

AJ Moreno-Ortega, FJ Martínez-Sanz… - …, 2015 - Elsevier
CALHM1 is a Ca 2+ channel discovered in 2008, which plays a key role in the neuronal
electrical activity, among other functions. However, there are no known efficient blockers …

Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP+

MST Mapa, VQ Le, K Wimalasena - PLoS One, 2018 - journals.plos.org
The discovery that 1-methyl-4-phenylpyridinium (MPP+) selectively destroys dopaminergic
neurons and causes Parkinson's disease (PD) symptoms in mammals has strengthened the …